Track Your Future Recoveries Withsnaptrade iconConnect Account

Akari Therapeutics, Plc Settlement
(NASDAQ: AKTX)
Settlement

Claim Deadline: October 15, 2018

Settlement Fund: $2,700,000

Settlement Class

All persons or entities that purchased the publicly-traded securities listed on United States stock exchanges of Akari  Therapeutics, plc (“Akari” or the “Company”) during the period from April 24, 2017 through May 30,  2017, both dates inclusive

Important Documents

Settlement Notice

Proof Of Claim

Settlement Status

Disbursed

Class Period

April 23, 2017 - August 25, 2017

Settlement Hearing Date

November 28, 2018

Opt-Out Deadline

November 07, 2018

Settlement Website

https://www.strategicclaims.net/akari-therapeutics-plc-securities-litigation/

Claims Admin

Strategic Claims Services
Akari Therapeutics, plc. Securities Litigationc/o Strategic Claims ServicesP.O. Box 230600 N. Jackson St., Ste. 205Media, PA 19063

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.